Literature DB >> 12627476

A "line item" approach to the identification of genes involved in polygenic behavioral disorders: the adrenergic alpha2A (ADRA2A) gene.

D E Comings1, N S Gonzalez, S-C Cheng Li, J MacMurray.   

Abstract

The usual approach for using single base pair polymorphisms (SNPs) for the investigation of the genetics of behavioral disorders is to examine a single diagnostic syndrome or personality trait based on variables relating to a cluster of behavioral symptoms. However, since some of these variables may address behaviors that are associated with one allele while others are associated with the other allele, the overall association may be non-significant and significant sub-syndromal associations may be missed. Thus, we have reversed the process in a technique we term a "line item" approach. As a test of the technique we have examined the association between genotypes of a C- > G-1291 Msp I promotor SNP of the ADRA2A gene and 390 individual symptoms from a structured review of DSM-IV criteria for twelve different groups of symptoms. We examined 334 individuals consisting of controls and subjects with Tourette syndrome (TS). Based on the mean scores for each genotype, those symptoms that were individually significant at alpha < or = 0.05 fell into three major groups by mode of inheritance: allele 1 codominant (11 > 12 > 22), allele 2 codominant (22 > 12 > 11), and negative heterosis (12 < 11, 22). Within each mode of inheritance group, the number of symptoms that were significant for the twelve symptom clusters was compared by chi-square analysis. This showed that symptoms were drawn from the diagnostic groups in a significantly non-random fashion. Thus, the allele 1 codominant symptoms came from the anxiety, affective, schizoid, and somatization diagnostic groups (internalizing symptoms) (chi(2) = 80.0, d.f. = 11, P < or = 0.0000001), while the allele 2 codominant symptoms came from the ADHD and oppositional defiant/conduct disorder diagnostic groups (externalizing symptoms) (chi(2) = 81.0, d.f. = 11, P < or = 0.0000001). The questions that fell in the negative heterosis type of inheritance were not significantly associated with specific diagnostic groups (P = 0.87). These results showed that the ADRA2A gene was associated with symptoms of autonomic, sympathetic dysfunction from different diagnostic groups. The advantages of the "line item" approach include (a) the identification of the symptoms associated with each allele, (b) the identification of symptom clusters independent of DSM diagnoses, (c) the elucidation of heterosis and other mode of inheritance effects, (d) the distinction between an association with a primary disorder versus a comorbid disorder, (e) the identification of associations with sub-syndromal symptom clusters that do meet full DSM-IV criteria, and (f) the identification of symptom clusters across databases. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12627476     DOI: 10.1002/ajmg.b.10056

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  10 in total

1.  A PTPN22 promoter polymorphism -1123G>C is associated with RA pathogenesis in Chinese.

Authors:  Jian-Jun Huang; Yu-Rong Qiu; Hai-Xia Li; De-Hua Sun; Jia Yang; Chun-Li Yang
Journal:  Rheumatol Int       Date:  2010-12-31       Impact factor: 2.631

2.  Candidate gene associations with withdrawn behavior.

Authors:  David H Rubin; Robert R Althoff; Erik A Ehli; Gareth E Davies; David C Rettew; Eileen T Crehan; John T Walkup; James J Hudziak
Journal:  J Child Psychol Psychiatry       Date:  2013-06-28       Impact factor: 8.982

3.  Effects of the serotonin transporter (5-HTTLPR) and α2A-adrenoceptor (C-1291G) genotypes on substance use in children and adolescents: a longitudinal study.

Authors:  Liis Merenäkk; Jarek Mäestu; Niklas Nordquist; Jüri Parik; Lars Oreland; Helle-Mai Loit; Jaanus Harro
Journal:  Psychopharmacology (Berl)       Date:  2010-12-08       Impact factor: 4.530

Review 4.  Molecular genetics of attention deficit hyperactivity disorder.

Authors:  Stephen V Faraone; Eric Mick
Journal:  Psychiatr Clin North Am       Date:  2010-03

5.  The adrenergic receptor alpha-2A gene (ADRA2A) and neuropsychological executive functions as putative endophenotypes for childhood ADHD.

Authors:  Irwin D Waldman; Joel T Nigg; Ian R Gizer; Leeyoung Park; Marsha D Rappley; Karen Friderici
Journal:  Cogn Affect Behav Neurosci       Date:  2006-03       Impact factor: 3.282

Review 6.  Candidate genes and neuropsychological phenotypes in children with ADHD: review of association studies.

Authors:  Oussama Kebir; Karim Tabbane; Sarojini Sengupta; Ridha Joober
Journal:  J Psychiatry Neurosci       Date:  2009-03       Impact factor: 6.186

Review 7.  Genetic and Neuroimaging Features of Personality Disorders: State of the Art.

Authors:  Guorong Ma; Hongying Fan; Chanchan Shen; Wei Wang
Journal:  Neurosci Bull       Date:  2016-04-01       Impact factor: 5.203

8.  Norepinephrine and dopamine modulate impulsivity on the five-choice serial reaction time task through opponent actions in the shell and core sub-regions of the nucleus accumbens.

Authors:  Daina Economidou; David E H Theobald; Trevor W Robbins; Barry J Everitt; Jeffrey W Dalley
Journal:  Neuropsychopharmacology       Date:  2012-04-18       Impact factor: 7.853

9.  Preliminary evidence for a role of the adrenergic nervous system in generalized anxiety disorder.

Authors:  Xiaobin Zhang; Joanna Norton; Isabelle Carrière; Karen Ritchie; Isabelle Chaudieu; Joanne Ryan; Marie-Laure Ancelin
Journal:  Sci Rep       Date:  2017-02-15       Impact factor: 4.379

10.  Effect of acute stressor and serotonin transporter genotype on amygdala first wave transcriptome in mice.

Authors:  Christa Hohoff; Ali Gorji; Sylvia Kaiser; Edith Willscher; Eberhard Korsching; Oliver Ambrée; Volker Arolt; Klaus-Peter Lesch; Norbert Sachser; Jürgen Deckert; Lars Lewejohann
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.